Page 835 - Read Online

Page 14 of 15 Bhangui et al. Hepatoma Res 2020;6:71 I http://dx.doi.org/10.20517/2394-5079.2020.67

Clin Oncol 2010;40:768-73.
34. Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, et al. Sirolimus use in liver transplant recipients with hepatocellular
carcinoma: a randomized, multicenter, open- label phase 3 trial. Transplantation 2016;100:116-25.
35. Zhang ZH, Li LX, Li P, Lv SC, Pan B, et al. Sirolimus in liver transplant recipients with hepatocellular carcinoma: an updated meta-
analysis. J Invest Surg 2019;32:632-41.
36. Jeng LB, Lee SG, Soin AS, Lee WC, Suh KS, et al. Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver
transplant recipients: 12-month results of a randomized multicenter study. Am J Transplant 2018;18:1435-46.
37. Cholongitas E, Mamou C, Rodríguez-Castro KI, Burra P. Mammalian target of rapamycin inhibitors are associated with lower rates of
hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int 2014;27:1039-49.
38. Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, et al. Effect of different immunosuppressive schedules on recurrence-free
survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010;89:227-31.
39. Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, et al. Sirolimus-based immunosuppression therapy in liver transplantation for patients with
hepatocellular carcinoma exceeding the Milan criteria. Transplant Proc 2008;40:3548-53.
40. Iavarone M, Invernizzi F, Czauderna C, Sanduzzi-Zamparelli M, Bhoori S, et al. Preliminary experience on safety of regorafenib after
sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. Am J Transplant 2019;19:3176-84.
41. Kittai AS, Oldham H, Cetnar J, Taylor M. Immune checkpoint inhibitors in organ transplant patients. J Immunother 2017;40:277-81.
42. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller C, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and
prognosis. Liver Transpl 2004;10:534-40.
43. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, et al. Pattern and management of recurrent hepatocellular carcinoma after
liver transplantation. J Hepatobiliary Pancreat Surg 1998;5:29-34.
44. Bodzin AS, Lunsford KE, Markovic D, Harlander-Locke MP, Busuttil RW, et al. Predicting mortality in patients developing
recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics. Ann Surg
2017;266:118-25.
45. Invenizzi F, Iavarone M, Donato MF, Mazzucco A, Torre M, et al. Pulmonary resection for metastasis of hepatocellular carcinoma
recurring after liver transplant: an Italian multicenter experience. Front Oncol 2020;10:381.
46. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, et al. The significance of surgical resection for pulmonary metastasis from
hepatocellular carcinoma. Am J Surg 2006;192:46-51.
47. Bates MJ, Farkas E, Taylor D, McFadden PM. Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation. Ann
Thorac Surg 2008;85:412-5.
48. Hwang S, Kim YH, Kim DK, Ahn CS, Moon DB, et al. Resection of pulmonary metastases from hepatocellular carcinoma following
liver transplantation. World J Surg 2012;36:1592-602.
49. Nakajima J, Tanaka M, Matsumoto J, Takeuchi E, Fukami T, et al. Appraisal of surgical treatment for pulmonary metastasis from
hepatocellular carcinoma. World J Surg 2005;29:715-8.
50. Poon RT, Fan ST, O’Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of
hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002;195:311-8.
51. O’Suilleabhain CB, Poon RT, Lau CW, Fan ST. Repeated resections of extrahepatic metastases after hepatic resection: an aggressive
approach to hepatocellular carcinoma. Hepatogastroenterology 2004;51:825-9.
52. Gwak GY, Jung JO, Sung SW, Lee HS. Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment
outcome or natural history? Hepatogastroenterology 2004;51:1428-33.
53. Han KN, Kim YT, Yoon JH, Suh KS, Song JY, et al. Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma.
Lung Cancer 2010;70:295-300.
54. Aoki M, Hatayama Y, Kawaguchi H, Hirose K, Sato M, et al. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a
single institutional study. J Radiat Res 2016;57:55-61.
55. Zhai H, Liang P, Yu XL, Cheng Z, Han ZY, et al. Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after
liver transplantation: an analysis of 11 cases. Int J Hyperthermia 2015;31:863-8.
56. Ko HK, Ko GY, Yoon HK, Sung KB. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma
after living donor liver transplantation. Korean J Radiol 2007;8:320-7.
57. Rivera L, Giap H, Miller W, Fisher J, Hillebrand DJ, et al. Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of
recurrent hepatocellular carcinoma after liver transplantation: a case report. World J Gastroenterol 2006;12:5729-32.
58. Huang J, Yan L, Wu H, Yang J, Liao M, et al. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver
transplantation? J Surg Res 2016;200:122-30.
59. Zhou B, Shan H, Zhu KS, Jiang ZB, Guan SH, et al. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent
hepatocellular carcinoma after orthotopic liver transplantation. J Vasc Interv Radiol 2010;21:333-8.
60. Toso C, Mentha G, Majno P. Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma
recurrence. J Hepatol 2013;59:3-5.
61. Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol
2014;20:3100-11.
62. Sharabi AB, Nirschl CJ, Kochel CM, Nirschl TR, Francica BJ, et al. Stereotactic radiation therapy augments antigen-Specific PD-1-
mediated antitumor immune responses via cross-presentation of tumor antigen. Cancer Immunol Res 2015;3:345-55.
63. Parker JJ, Jones JC, Strober S, Knox SJ. Characterization of direct radiation-induced immune function and molecular signalling changes